Laboratory indicators of coronavirus infection COVID-19


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

This review provides literature data on the features of changes in the indicators of clinical and biochemical analysis of blood, as well as hemostatic and fibrinolysis systems in patients with new coronavirus infection COVID-19. It was shown that changes in indicators of clinical and biochemical blood analysis, as well as hemostatic and fibrinolysis systems with COVID-19, have their own characteristics and are closely interrelated with the severity of infection. In a clinical blood test, lymphopenia and thrombocytopenia are most common in this category of patients. Among blood biochemical parameters with COVID-19, an increase in CRP and ferritin levels, as well as a decrease in albumin levels, are more often detected. It should be noted that in y3 of severe patients with COVID-19 infection, the activity of liver enzymes, ALT and AST, increases. Among the indicators of hemostasis and fibrinolysis systems, an increase in the concentration of D-dimer in blood plasma is more often detected.

全文:

受限制的访问

作者简介

R. Abdullaev

Central Research Institute of Tuberculosis

Email: rizvan0403@yandex.ru
Professor, MD Moscow

O. Komissarova

Central Research Institute of Tuberculosis; N.I. Pirogov Russian National Research Medical University

Email: rizvan0403@yandex.ru
Professor, MD Moscow

参考

  1. Chen N., Zhou M., Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395 (10223): 507-13. doi: 10.1016/S0140-6736(20)30211-7
  2. Chen H., Guo J., Wang C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395 (10226): 809-15. doi: 10.1016/S0140-6736(20)30360-3
  3. Guan W.J., Ni Z.Y., Hu Y. et al. China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 Feb 28. doi: 10.1056/NEJMoa2002032.records. Lancet. February 12, 2020. DOI: 10.1016/ S0140-6736(20)30360-3
  4. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
  5. Lippi G., Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin. Chem. Lab. Med. (CCLM). 2020. doi: 10.1515/cclm-2020-0198. Published online: 03 Mar 2020
  6. Lippi G., Plebani M., Henry B.M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin. Chim. Acta. 2020; 506: 145-8. doi: 10.1016/j.cca.2020.03.022
  7. Lippi G., Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol, Transfus. Cell Ther. 2020. doi: 10.1016/j.htct.2020.03.001
  8. Liu W., Li H. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. Chem. Rxiv. Preprint. 2020. https://doi.org/10.26434/chemrxiv.11938173.v6
  9. Liu Y., Yang Y., Zhang C. et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci. China Life Sci. 2020; 63 (3): 364-74. doi: 10.1007/s11427-020-1643-8
  10. Tang N., Li D., Wang X. et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020; 18 (4): 844-7. doi: 10.1111/jth.14768
  11. Tang N., Bai H., Chen X. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020. doi: 10.1111/jth.14817
  12. Wang D., Hu B., Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J. Am. Med. Assoc. 2020. doi: 10.1001/jama.2020.1585
  13. Wang X.F., Yuan J., Zheng Y.J. et al. Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen. Zhonghua Er Ke Za Zhi. 2020; 58: E008.
  14. Zhang J.J., Dong X., Cao Y.Y. et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. 2020. doi: 10.1111/all.14238

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##